Irvine, Edward B.
Nikolov, Angel
Khan, Mehak Z.
Peters, Joshua M.
Lu, Richard
Sixsmith, Jaimie
Wallace, Aaron
van Woudenbergh, Esther http://orcid.org/0000-0001-7363-6649
Shin, Sally
Karpinski, Wiktor
Hsiao, Jeff C. http://orcid.org/0000-0003-0800-9977
Casadevall, Arturo http://orcid.org/0000-0002-9402-9167
Bryson, Bryan D. http://orcid.org/0000-0003-1716-6712
Cavacini, Lisa http://orcid.org/0000-0003-1417-8339
Grace, Patricia S.
Alter, Galit http://orcid.org/0000-0002-7680-9215
Fortune, Sarah M. http://orcid.org/0000-0001-7565-9975
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1156795, OPP1156795)
Foundation for the National Institutes of Health (75N93019C00071, AI150171-01, 75N93019C00071, R01A1022553, U54CA225088, U2CCA233262, U2CCA233280, 75N93019C00071)
Article History
Received: 27 April 2022
Accepted: 9 July 2024
First Online: 22 August 2024
Competing interests
: G.A. is an employee of Moderna Therapeutics and holds equity in Leyden Labs and Seromyx Systems. M.Z.K. is an employee of Moderna Therapeutics. The other authors declare no competing interests.